[astatine]

I have seen several situations where this would be desirable - notably bleeding startups with vc money. There is plenty of window dressing to capitalise expenses and show a better EBITDA.

What this will do is immediately reclassify large chunks of people out of "R&D" into operational resources. Just enough to balance between nice looking EBITDA and low real profit (= low tax)